2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide

C26H30N10O2S2 — CID 129136029

IUPAC2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide
SMILESCNc1nc(CC(=O)Nc2ccc([C@H]3CCC[C@H](c4ccc(NC(=O)Cc5csc(NC)n5)nn4)C3)nn2)cs1
InChIInChI=1S/C26H30N10O2S2/c1-27-25-29-17(13-39-25)11-23(37)31-21-8-6-19(33-35-21)15-4-3-5-16(10-15)20-7-9-22(36-34-20)32-24(38)12-18-14-40-26(28-2)30-18/h6-9,13-16H,3-5,10-12H2,1-2H3,(H,27,29)(H,28,30)(H,31,35,37)(H,32,36,38)/t15-,16-/m0/s1
InChIKeyOZHJCBDPPQHXTC-HOTGVXAUSA-N
MW578.73 g/mol
LogP4.07
Rot. Bonds10

About 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide

2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide (PubChem CID 129136029) has the molecular formula C26H30N10O2S2 and a molecular weight of 578.73 g/mol. Its IUPAC name is 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide.

Molecular Properties

Compound Name2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide
PubChem CID129136029
Molecular FormulaC26H30N10O2S2
Molecular Weight578.73 g/mol
Exact Mass578.20
IUPAC Name2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide
SMILESCNc1nc(CC(=O)Nc2ccc([C@H]3CCC[C@H](c4ccc(NC(=O)Cc5csc(NC)n5)nn4)C3)nn2)cs1
InChIInChI=1S/C26H30N10O2S2/c1-27-25-29-17(13-39-25)11-23(37)31-21-8-6-19(33-35-21)15-4-3-5-16(10-15)20-7-9-22(36-34-20)32-24(38)12-18-14-40-26(28-2)30-18/h6-9,13-16H,3-5,10-12H2,1-2H3,(H,27,29)(H,28,30)(H,31,35,37)(H,32,36,38)/t15-,16-/m0/s1
InChIKeyOZHJCBDPPQHXTC-HOTGVXAUSA-N
XLogP4.07
TPSA159.60 Ų
H-Bond Donors4
H-Bond Acceptors12
Rotatable Bonds10
Heavy Atoms40
Complexity

Lipinski Rule of Five

2 violations

RuleValue
MW ≤ 500578.73
LogP ≤ 54.07
H-Bond Donors ≤ 54
H-Bond Acceptors ≤ 1012

Analyze 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide?
The IUPAC name of 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide (CID 129136029) is 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide.
What is the SMILES notation for 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide?
The canonical SMILES for 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide is CNc1nc(CC(=O)Nc2ccc([C@H]3CCC[C@H](c4ccc(NC(=O)Cc5csc(NC)n5)nn4)C3)nn2)cs1.
What is the InChIKey of 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide?
The InChIKey is OZHJCBDPPQHXTC-HOTGVXAUSA-N. The full InChI is InChI=1S/C26H30N10O2S2/c1-27-25-29-17(13-39-25)11-23(37)31-21-8-6-19(33-35-21)15-4-3-5-16(10-15)20-7-9-22(36-34-20)32-24(38)12-18-14-40-26(28-2)30-18/h6-9,13-16H,3-5,10-12H2,1-2H3,(H,27,29)(H,28,30)(H,31,35,37)(H,32,36,38)/t15-,16-/m0/s1.
What are the key properties of 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide?
2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide has a molecular weight of 578.73 g/mol, XLogP of 4.07, 10 rotatable bonds, 4 hydrogen bond donors, and 12 hydrogen bond acceptors.
Where does this data come from?
All data for 2-[2-(methylamino)-1,3-thiazol-4-yl]-N-[6-[(1S,3S)-3-[6-[[2-[2-(methylamino)-1,3-thiazol-4-yl]acetyl]amino]pyridazin-3-yl]cyclohexyl]pyridazin-3-yl]acetamide is sourced from PubChem (CID 129136029), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).